$Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction$
QR Code

QR Code

Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction

Aim. To study the prognostic value of high serum concentration of soluble ST2 protein (sST2) in the development of cardiovascular events after endovascular myocardial revascularization and the possibility of using this biomarker as a target for β-blocker therapy in patients with chronic heart failur...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Grakova, K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, V. V. Kalyuzhin
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2022-04-01
Series:	Бюллетень сибирской медицины
Subjects:	chronic heart failure left ventricle preserved and mildly reduced ejection fraction β-blockers biomarkers soluble st2 n-terminal pro-brain natriuretic peptide prognosis endovascular revascularization
Online Access:	https://bulletin.ssmu.ru/jour/article/view/4694
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01)

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report
by: E. A. Pravkina, et al.
Published: (2023-07-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Efficiency of meldonium application in complex treatment of patients with chronic heart failure decompensation
by: A. S. Sycheva, et al.
Published: (2021-06-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

HEART TRANSPLANTATION FROM DONORS WITH LEFT VENTRICULAR EJECTION FRACTION <40%
by: V. N. Poptsov, et al.
Published: (2018-06-01)

Point-of-care N-terminal pro-brain natriuretic peptide testing in patients with heart failure: data from the DREAM study
by: F. I. Belyalov, et al.
Published: (2024-06-01)

Possible risk factors for atrial fibrillation in patients with heart failure with mildly reduced ejection fraction
by: L. G. Azarapetyan, et al.
Published: (2024-04-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)

DIABETES MELLITUS 2ND TYPE WITH CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2015-09-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Effects of Acute Exercise Bouts on Cardiovascular Biomarkers in Runners with Exercise-Induced Hypertension
by: Young-Joo Kim, et al.
Published: (2025-06-01)

CENTRAL HEMODYNAMIC PARAMETERS IN PATIENTS WITH IDIOPATHIC ATRIAL FIBRILLATION
by: K. V. trakhova, et al.
Published: (2011-06-01)

Cardiac remodeling in patients with heart failure with mildly reduced ejection fraction and metabolic disorders: association with biomarkers and autonomic nervous system parameters
by: E. A. Lyasnikova, et al.
Published: (2024-05-01)

LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE
by: M. A. Babaev, et al.
Published: (2017-03-01)

Significance of Markers of Transient Myocardial Ischemia and Hemodynamic Overload in Critically Ill Neonates
by: K. V. Budarova, et al.
Published: (2022-10-01)

Integral assessment of congestion in patients with acute decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2022-03-01)

The level of N-terminal pro-brain natriuretic peptide depending on vascular wall condition and bone mass in postmenopausal women
by: I. A. Skripnikova, et al.
Published: (2020-07-01)

Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01)

Evaluation N-terminal pro-B-type natriuretic peptide and other biochemical parameters in heart failure with or without chronic kidney disease in Kirkuk city
by: Firas Tariq, et al.
Published: (2024-10-01)

High sympathetic tone in development of the left ventricle hypertrophy and beta-blockers for regression
by: О. D. Ostroumova, et al.
Published: (2018-09-01)

Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability
by: E. V. Grakova, et al.
Published: (2023-07-01)

Diastolic heart failure: boundaries of term application
by: V. V. Kalyuzhin, et al.
Published: (2023-04-01)

NEW OPPORTUNITIES IN TREATMENT OF CHRONIC HEART FAILURE WITH NORMAL EJECTION FRACTION
by: A. G. Dushina, et al.
Published: (2015-08-01)

Factors affecting the effectiveness of endovascular kidney revascularization in patients with renal arteria stenosis
by: E. V. Frolova, et al.
Published: (2020-12-01)

Predicting solubility of fluoropolymers.
by: M. Y. Boksha, et al.
Published: (2009-12-01)

Position of Patients with Mid-Range Ejection Fraction in the General Chronic Heart Failure Population
by: N. T. Vatutin, et al.
Published: (2021-03-01)

Factors associated with long-term adverse cardiovascular events in patients with type 2 diabetes
by: A. A. Demin, et al.
Published: (2021-12-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

COMPARISON OF EJECTION FRACTION AND END VOLUMES OF THE LEFT VENTRICLE AS INDICATORS OF THE SEVERITY OF HEART FAILURE
by: Dinara Sh. Gazizova
Published: (2019-07-01)

Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization
by: E. V. Grakova, et al.
Published: (2018-10-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
by: A. A. Klimenko, et al.
Published: (2015-09-01)

Predictors of an adverse course of heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome
by: A. T. Teplyakov, et al.
Published: (2021-07-01)

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect
by: M. T. Duishenalieva, et al.
Published: (2025-05-01)

The results of standard echocardiography and use of Velocity Vector Imaging technology after surgical revascularization in patients with coronary artery disease
by: A. Yu. Vasiliev, et al.
Published: (2019-08-01)

CMR Left Ventricular Filling Pressure Exhibits Strong Haemodynamic Relevance and Outperforms Echocardiography in Multimodal Heart Failure Assessment
by: Aradhai Bana, et al.
Published: (2025-06-01)